Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[These tumors account for 12-17 % of all breast cancers, preferentially affect young women, are more frequent in women of African and Hispanic descent, and are enriched in the population of patients diagnosed with interval cancers. TNBCs account for the majority of breast cancers arising in BRCA1 germline mutation carriers (approximately 80%), and approximately 11-16% of all TNBCs harbor BRCA1 or BRCA2 germline mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP1249860.RAceya8V_SvbMYdyhCzgyr1AWvSkXjfeKQQilQJ9j6ETo130_assertion description "[These tumors account for 12-17 % of all breast cancers, preferentially affect young women, are more frequent in women of African and Hispanic descent, and are enriched in the population of patients diagnosed with interval cancers. TNBCs account for the majority of breast cancers arising in BRCA1 germline mutation carriers (approximately 80%), and approximately 11-16% of all TNBCs harbor BRCA1 or BRCA2 germline mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249860.RAceya8V_SvbMYdyhCzgyr1AWvSkXjfeKQQilQJ9j6ETo130_provenance.
• NP1249862.RAQooySkJKicKcAq04YJtH7NkgY4JSc8vhYo9yTipAKkc130_assertion description "[These tumors account for 12-17 % of all breast cancers, preferentially affect young women, are more frequent in women of African and Hispanic descent, and are enriched in the population of patients diagnosed with interval cancers. TNBCs account for the majority of breast cancers arising in BRCA1 germline mutation carriers (approximately 80%), and approximately 11-16% of all TNBCs harbor BRCA1 or BRCA2 germline mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249862.RAQooySkJKicKcAq04YJtH7NkgY4JSc8vhYo9yTipAKkc130_provenance.
• NP1249858.RAkF1GsuRGqAZ-5u_0Lfyq3SMSPvqk35T8qxb81KLw9Uw130_assertion description "[These tumors account for 12-17 % of all breast cancers, preferentially affect young women, are more frequent in women of African and Hispanic descent, and are enriched in the population of patients diagnosed with interval cancers. TNBCs account for the majority of breast cancers arising in BRCA1 germline mutation carriers (approximately 80%), and approximately 11-16% of all TNBCs harbor BRCA1 or BRCA2 germline mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249858.RAkF1GsuRGqAZ-5u_0Lfyq3SMSPvqk35T8qxb81KLw9Uw130_provenance.
• NP1249865.RAODnPfej6-W7p_OJmVeMvAPgfI9QWWPV1BlhGFR-TQzI130_assertion description "[These tumors account for 12-17 % of all breast cancers, preferentially affect young women, are more frequent in women of African and Hispanic descent, and are enriched in the population of patients diagnosed with interval cancers. TNBCs account for the majority of breast cancers arising in BRCA1 germline mutation carriers (approximately 80%), and approximately 11-16% of all TNBCs harbor BRCA1 or BRCA2 germline mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249865.RAODnPfej6-W7p_OJmVeMvAPgfI9QWWPV1BlhGFR-TQzI130_provenance.
• NP1249861.RA-6i87HrjgL8jIEa2bEbWeJznLyjYmSi73tO3l0qB8IE130_assertion description "[These tumors account for 12-17 % of all breast cancers, preferentially affect young women, are more frequent in women of African and Hispanic descent, and are enriched in the population of patients diagnosed with interval cancers. TNBCs account for the majority of breast cancers arising in BRCA1 germline mutation carriers (approximately 80%), and approximately 11-16% of all TNBCs harbor BRCA1 or BRCA2 germline mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249861.RA-6i87HrjgL8jIEa2bEbWeJznLyjYmSi73tO3l0qB8IE130_provenance.